110 Stakeholder consultation for feedback on SEC meetings dated 22.04.2024 2024-Apr-22 272 KB
In force — no superseding record on file.
File No. 12-01/2024-DC (SEC)
Directorate General of Health Services
Central Drugs Standard Control Organization (SEC Division)
FDA Bhawan, Kotla Road, New Delhi- 110002 Dated: 22-0-202\
Subject:- Stakeholder consultation for feedback on Subject Expert Committee (SEC) meetings — regarding
In order to align the working of SEC meetings with stakeholders expectations, a consultation meeting is scheduled to be held on 26™ April 2024 at CDSCO (HQ) from 05:00 PM to 06:00 PM. Stakeholders are requested to nominate their representative well versed with the subject for the said meeting.
Nomination may be sent through e-mail at dci@nic.in & expert-committee@cdsco.nic.in.
The virtual link to join the meeting through webex will be sent to your e-mail. (AnkitSharma)74 Deputy Drugs Controller (India)
Copy to:-
-
All the stakeholders.
-
Indian Drug/Pharmaceuticals Association (IDMA/FOPE/CIPI/IPA/OPPI, etc.).
-
Website of CDSCO for information.
-
PS to DCG (I).
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24621 --apply.